Skip to content

Fusing Ultrasound and Magnetic Resonance Imaging to Intelligently Plan Highly Conformal Ablation Thermal Field for Hepatocellular Carcinoma

Fusing Ultrasound and Magnetic Resonance Imaging to Intelligently Plan Highly Conformal Ablation Thermal Field for Hepatocellular Carcinoma

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06798194
Enrollment
300
Registered
2025-01-29
Start date
2025-01-30
Completion date
2027-12-30
Last updated
2025-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Brief summary

Thermal ablation is an important minimally invasive treatment for hepatocellular carcinoma (HCC), but local tumor progression (LTP) after ablation restricts the efficacy and status of ablation technology and seriously threatens patient survival. Insufficient coverage of thermal field is an important factor on the occurrence of LTP. Current thermal field planning relies on tumor contours and doctor experience, and the safety margin is uniform. Therefore, it cannot cope with the problem of insufficient coverage of thermal field caused by the different invasion capabilities of different tumors and different parts of the same tumor. This project intends to integratively analyze gray-scale ultrasound, contrast-enhanced ultrasound, magnetic resonance imaging and clinical information of HCC through deep canonical correlation analysis; summarize the prior knowledge of LTP risk factors in previous studies and perform conjoint analysis individual case data and common conclusions through knowledge graph; interpretatively predict the LTP risk and the high-risk LTP locations through link prediction; accurately predict the ablation safety margin required for different tumor parts through graph neural network, and achieve highly conformal thermal field planning based on different invasion capabilities to minimize the LTP risk of HCC. The project leverages tumor multi-modal imaging and prior knowledge as the entry point, performs highly conformal planning of the ablation thermal field through artificial intelligence technology, and provides a new method for precise ablation.

Interventions

DIAGNOSTIC_TESTPost-ablation MRI is used to evaluate whether the ablation area of the tumor is consistent with the highly conformal ablation thermal field provided by the AI model.

This study developed an AI model that can provide optimal highly conformal ablation thermal field for HCC patients using ultrasound and MRI. Post-ablation MRI is used to evaluate whether the ablation area of the tumor is consistent with the highly conformal ablation thermal field provided by the AI model. The patients were divided into: 1. Actual ablation zone of the tumor was consistent with the highly conformal ablation thermal field (consistent group); 2. Actual ablation zone of the tumor was inconsistent with the highly conformal ablation thermal field (inconsistent group).

Sponsors

Chinese PLA General Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Pathologically confirmed primary hepatocellular carcinoma 2. Undergo curative ablation 3. With complete clinical information and pre- and post-operative imaging information

Exclusion criteria

1. Undergo palliative ablation 2. Lack of clinical or imaging information 3. Age less than 18 years

Design outcomes

Primary

MeasureTime frameDescription
Local tumor progression2 yearsAfter HCC ablation, tumor recurrence appears around the ablation area

Secondary

MeasureTime frameDescription
tumor recurrence2 yearTumor recurrence after HCC ablation

Countries

China

Contacts

Primary ContactWenzhen Ding, Dr
923345765@qq.com+86 66939530

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026